Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


Innate Pharma Says First Patient Dosed In IPH6101/SAR443579 Phase 1/2 Clinical Trial In Various Blood Cancers


RTTNews | Dec 16, 2021 01:05AM EST

01:05 Thursday, December 16, 2021 (RTTNews) - Innate Pharma Says First Patient Dosed In IPH6101/SAR443579 Phase 1/2 Clinical Trial In Various Blood Cancers

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC